...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Events

Tada,

I agree that it is time for a quarterly update. Last year, they gave a Q1 update in January and then not another update until towards the end of Q2 on June 20, 2016. Our last webcast was at the Annual Meeting in mid-December 2016. Although they made available the slide decks from their January 2017 Biotech Showcase presentation and their BIO CEO Feburary 2017 presentation, as well as their AACR 2017 poster (mainly pre-clinical), these slides and poster contained very little new information.

In other words, we haven't had a substantial update in about 4 1/2 months. I sure hope we don't have to wait until end of June for the next update like last year. But if we do have to wait, it had better be for good reason!

BearDownAZ

Share
New Message
Please login to post a reply